146 related articles for article (PubMed ID: 11576468)
1. The neutralization of interferons by antibody. II. Neutralizing antibody unitage and its relationship to bioassay sensitivity: the tenfold reduction unit.
Grossberg SE; Kawade Y; Kohase M; Klein JP
J Interferon Cytokine Res; 2001 Sep; 21(9):743-55. PubMed ID: 11576468
[TBL] [Abstract][Full Text] [Related]
2. The neutralization of interferons by antibody. I. Quantitative and theoretical analyses of the neutralization reaction in different bioassay systems.
Grossberg SE; Kawade Y; Kohase M; Yokoyama H; Finter N
J Interferon Cytokine Res; 2001 Sep; 21(9):729-42. PubMed ID: 11576467
[TBL] [Abstract][Full Text] [Related]
3. The neutralization of interferons by antibody III. The constant antibody bioassay, a highly sensitive quantitative detector of low antibody levels.
Grossberg SE; Kawade Y; Grossberg LD
J Interferon Cytokine Res; 2009 Feb; 29(2):93-104. PubMed ID: 19000020
[TBL] [Abstract][Full Text] [Related]
4. The expression of potency of neutralizing antibodies for interferons and other cytokines.
Grossberg SE; Kawade Y
Biotherapy; 1997; 10(1):93-8. PubMed ID: 9261553
[TBL] [Abstract][Full Text] [Related]
5. Perspectives on the neutralization of interferons by antibody.
Grossberg SE
Neurology; 2003 Nov; 61(9 Suppl 5):S21-3. PubMed ID: 14610106
[TBL] [Abstract][Full Text] [Related]
6. An analysis of neutralization reaction of interferon by antibody: a proposal on the expression of neutralization titer.
Kawade Y
J Interferon Res; 1980; 1(1):61-70. PubMed ID: 6180046
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of an interferon-beta1a product.
Kauffman MA; Sterin-Prync A; Papouchado M; González E; Vidal AJ; Grossberg SE; Chuppa S; Odoriz B; Vrech C; Diez RA; Ferro HH
Int J Immunopathol Pharmacol; 2011; 24(2):499-504. PubMed ID: 21658324
[TBL] [Abstract][Full Text] [Related]
8. Sensitive antiproliferative neutralization assay for the detection of neutralizing IFN-alpha and IFN-beta antibodies.
Prümmer O; Streichan U; Heimpel H; Porzsolt F
J Immunol Methods; 1994 May; 171(1):45-53. PubMed ID: 8176238
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of interferon by antibody: appraisals of methods of determining and expressing the neutralization titer.
Kawade Y; Watanabe Y
J Interferon Res; 1984; 4(4):571-84. PubMed ID: 6389723
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta.
Bertolotto A; Sala A; Caldano M; Capobianco M; Malucchi S; Marnetto F; Gilli F
J Immunol Methods; 2007 Apr; 321(1-2):19-31. PubMed ID: 17335844
[TBL] [Abstract][Full Text] [Related]
11. Production and characterization of four monoclonal antibodies specific for human interferon-alpha-1 and -alpha-2.
Noll F; Handschack W; Eichmann E; Gaestel M; Schneider F; Kuhl R; Löster K
Biomed Biochim Acta; 1989; 48(1):165-76. PubMed ID: 2775248
[TBL] [Abstract][Full Text] [Related]
12. Measurement of neutralising antibodies to type I interferons by gene expression assays specific for type 1 interferon-inducible 6-16 mRNA.
Moore M; Meager A; Wadhwa M; Burns C
J Pharm Biomed Anal; 2009 Feb; 49(2):534-9. PubMed ID: 19097723
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta.
Hermanrud C; Ryner M; Luft T; Jensen PE; Ingenhoven K; Rat D; Deisenhammer F; Sørensen PS; Pallardy M; Sikkema D; Bertotti E; Kramer D; Creeke P; Fogdell-Hahn A;
J Immunol Methods; 2016 Mar; 430():1-9. PubMed ID: 26779831
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of the biological activity of cytokines and other protein effectors by antibody: theoretical formulation of antibody titration curves in relation to antibody affinity.
Kawade Y; Finter N; Grossberg SE
J Immunol Methods; 2003 Jul; 278(1-2):127-44. PubMed ID: 12957402
[TBL] [Abstract][Full Text] [Related]
15. Anti-interferon antibodies to interferon-alpha 2b: results of comparative assays and clinical perspective.
Spiegel RJ; Jacobs SL; Treuhaft MW
J Interferon Res; 1989 Sep; 9 Suppl 1():S17-24. PubMed ID: 2553829
[TBL] [Abstract][Full Text] [Related]
16. Differential neutralizing activity of human antibodies in interferon antiviral and natural killer cell bioassays.
Thurmond LM; Reese MJ
J Interferon Cytokine Res; 1997 Oct; 17(10):619-23. PubMed ID: 9355963
[TBL] [Abstract][Full Text] [Related]
17. A novel bioassay for the determination of neutralizing antibodies to IFN-beta1b.
Pungor E; Files JG; Gabe JD; Do LT; Foley WP; Gray JL; Nelson JW; Nestaas E; Taylor JL; Grossberg SE
J Interferon Cytokine Res; 1998 Dec; 18(12):1025-30. PubMed ID: 9877445
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha neutralizing antibodies in HIV and chronic HCV patients treated with natural-source human leukocyte-derived interferon-alpha n3.
Zhao XX; Hua J; Smith T; Ferencz-Biro K; Liao MJ; Rashidbaigi A
Hum Antibodies; 1997; 8(3):129-36. PubMed ID: 9322083
[TBL] [Abstract][Full Text] [Related]
19. A novel assay to detect low-titred antibodies to interferon beta in multiple sclerosis patients.
Di Marco P; Pagnotti P; Bellomi F; De Vito G; Sessa E; Bagnato F; Scagnolari C; Bramanti P; Antonelli G
New Microbiol; 2006 Jan; 29(1):11-8. PubMed ID: 16608120
[TBL] [Abstract][Full Text] [Related]
20. Low incidence of neutralizing antibody formation to interferon-alpha 2b in human recipients.
Dianzani F; Antonelli G; Amicucci P; Cefaro A; Pintus C
J Interferon Res; 1989 Sep; 9 Suppl 1():S33-6. PubMed ID: 2681442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
